EUVIMEDEUVIMED entdecken
Crossref

Abstract TH108: Antihypertensive Mechanism Determines Retinal Hemodynamics in Isolated Systolic Hypertension

Breanna Pederson, Amy Stroud, Matthew K Armstrong, Randy Kardon, Gary L Pierce

Hypertension · 2026-10 · 83 (Suppl_1)

DOI: 10.1161/hyp.83.suppl_1.th108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Breanna Pederson und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Isolated systolic hypertension (ISH) is associated with damaging pulsatile pressure and flow which penetrates into the small vessels of high flow end-organs such as the retina. The retinal microvasculature is easily accessible vascular bed that can provide insight into the effect of different antihypertensive agents, such as central sympathetic inhibition (clonidine) and volume depletion (hydrochlorothiazide, HCTZ), on end-organ flow hemodynamics in the presence of similar blood pressure (BP) reduction. We hypothesized that retinal arteriolar and venular flow hemodynamics in response to each antihypertensive treatments would differ despite equivalent BP reduction in ISH.

Methods

Adults with ISH (n=20; age=40-84 yrs; systolic BP 138-173 mmHg) were randomized for 4 weeks to 0.2 mg/day clonidine (n=8), 37.5 mg HCTZ (n=6), or placebo (n=6) after a 7-day washout. Retinal flow hemodynamics were assessed at baseline and after 4 weeks using laser speckle flowgraphy (LSFG) with total retinal artery and vein blood flow analysis. Primary outcomes were flow pulsatility index (PI), flow pulse amplitude, relative flow volume (RFV), resistivity index (RI); and choroidal mean blur rate (blood flow velocity) as a control.

Results

Both agents produced equivalent systolic BP reductions (HCTZ –9.6%, clonidine –10.2%, p0.56, between groups p=1). Despite equivalent BP reductions, venous flow responses diverged significantly: HCTZ significantly reduced PI (–30.4%, p=0.031), pulse amplitude (–33.9%, p=0.031), and RI (–25.5%, p=0.031), compared to both placebo and clonidine (p0.31). or relative flow volume for venules (p>0.38) or arterioles (p>0.55).

Conclusions

Equivalent BP reductions produced diverging retinal flow hemodynamics outcomes by antihypertensive drug mechanism. HCTZ selectively reduced venous flow pulsatility and resistance without altering volume flow, in the absence of changes after clonidine. Arteriolar flow pulsatility was not significantly altered between treatment groups, although clonidine and HCTZ produced a trend for opposite effects in arteriolar PI. Future larger studies should evaluate consequences of different antihypertensive treatment on arteriolar and venular pulsatility in high flow end-organ microvasculature.

Zitieren

APA

Pederson, B., Stroud, A., Armstrong, M. K., Kardon, R., & Pierce, G. L. (2026). Abstract TH108: Antihypertensive Mechanism Determines Retinal Hemodynamics in Isolated Systolic Hypertension. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.th108

Vancouver

Pederson B, Stroud A, Armstrong MK, Kardon R, Pierce GL. Abstract TH108: Antihypertensive Mechanism Determines Retinal Hemodynamics in Isolated Systolic Hypertension. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.th108

BibTeX
@article{Pederson2026,
  author = {Pederson, Breanna and Stroud, Amy and Armstrong, Matthew K and Kardon, Randy and Pierce, Gary L},
  title = {Abstract TH108: Antihypertensive Mechanism Determines Retinal Hemodynamics in Isolated Systolic Hypertension},
  journal = {Hypertension},
  year = {2026},
  volume = {83},
  number = {Suppl_1},
  doi = {10.1161/hyp.83.suppl_1.th108}
}
Kostenlos starten →